A ctivation of T cells by the MHC/peptide complex may occur in three correlated ways: 1) direct interaction of the TCR with the MHC, termed MHC restriction; 2) direct interaction of the TCR with solvent-accessible peptide main chain and side chains; and 3) indirect interaction of peptide with TCR mediated via conformational perturbations in the MHC complex (1, 2) . Crystallographic studies clearly showed that substitutions occurring at the peptides not only impact the exposed structure of the peptides, but they also lead to the induced fit on the helices of MHC that form the peptide-binding groove (3). This differential tuning of the dynamic properties of MHC molecules by the peptides thus may impact TCR recognition (4) . Furthermore, the binding peptide-affected portions on MHC protein comprise not only the regions contacted by TCRs but also other activating and inhibitory receptors of the immune system, such as the CD8 coreceptor and NK receptors (5) . However, it is still largely unknown whether the conformational shift of MHC class I (MHC I) impacts the protection of Ag-specific T cells against specific virus infection.
In mid-2012, a novel coronavirus termed Middle East respiratory syndrome coronavirus (MERS-CoV) originated in Middle Eastern countries. Later, imported cases were reported in countries from other continents (6) (7) (8) , including South Korea and China in 2015 (9) (10) (11) . The limited clues of adaptive immunity against MERS-CoV infection revealed that in patients infected with MERS-CoV, weak and delayed Ab responses are associated with more severe disease or fatal outcomes (12) (13) (14) . However, recent evidence indicates that the neutralizing Ab levels in MERS patients are weakly and inversely correlated with the viral loads in the lower respiratory tract (13) . This may indicate that the presence of Abs does not lead to the elimination of the virus from the lower respiratory tract. For the MERS-CoV-specific T cell responses, PBMCs obtained on day 24 of illness show a strong, specific T cell response against MERS-CoV spike protein (S protein) (15) . Lymphocyte counts rapidly increased up to 10 d after symptom onset in MERS patients with or without mild pneumonia, whereas all of the deceased patients displayed rapid drops in their lymphocyte counts, suggesting that adaptive immune responses play a protective role (14) . However, the molecular basis of MERS-CoV-specific T cell recognition during virus infection is still largely known.
Thus far, MERS-CoV vaccines have provided efficacious protection in animal models (16) , although none of the vaccines has been applied in human clinical trials. Major strategies for vaccine development focus on the elicitation of immunity against the major Ag (S protein) of MERS-CoV (17, 18) . Vaccination with recombinant receptor-binding domain protein induces robust Abs, alleviates pneumonia, and decreases viral load in monkeys (19) . However, studies also demonstrate that MERS-CoV S proteinderived vaccines induce specific CD8 + T cell and virus-neutralizing Abs, which can contribute to complete protection against MERS-CoV in animal models (20, 21) . Our recently developed MERS vaccines using an adenoviral-based encoded S protein induce strong neutralizing Abs and T cell immune responses, protecting immunized mice from challenge with MERS-CoV (22) . However, knowledge is still limited concerning the T cell-mediated immunity of MERS-CoV among mice, which could be a useful research model for MERS-CoV vaccine development.
In this study, we evaluated the T cell immunogenicity of MERS-CoV S protein in a mouse model by using the overlapping peptides spanning the whole S protein. The MERS-CoV-derived T cell peptide possesses a feature to induce MHC fitting that has a pivotal impact on the immunogenicity of the peptide and its protective efficacy against MERS-CoV infection. These data demonstrate that T cells play a crucial but featured role in MERS-CoV clearance and may illuminate new avenues for vaccine development.
Materials and Methods

Mice
Six-to eight-week-old female BALB/c mice were purchased from the Animal Care Center of the Chinese Academy of Medical Science (Beijing, China) and maintained under specific pathogen-free conditions. All experiments were performed in strict compliance with the Guide for the Care and Use of Laboratory Animals of the People's Republic of China, and approved by the Committee on the Ethics of Animal Experiments of the Chinese Center for Disease Control and Prevention.
Animal immunization with MERS-CoV S protein vaccines
To evaluate the T cell immunogenicity of the MERS-CoV S protein, BALB/c mice were i.m. immunized with rAd5-S, an adenoviral-based S protein vaccine constructed in our laboratory (22) , at a dosage of 5 3 10 9 virus particles. Two weeks later, the mice were sacrificed to harvest spleens.
For the antigenic comparison of peptide 37-1 and its substitution I5A, BALB/c mice were immunized through a prime/boost strategy. The cDNA pCAGGS-S vaccine expressing the S protein of MERS-CoV was used to immunize the mice, followed by a boost through a vaccinia vector vaccine rVV-Sq carrying the ectodomain of S protein. The T cell immune responses were detected 2 wk after the last injection.
Peptide immunization and MERS-CoV challenge
During the animal immunization with the Ag peptide, the mice were randomly divided into three groups. The mice in the control groups were immunized with adjuvants of 100 ml of IFA and 10 mg of murine heat shock protein gp96 (23) . The mice in the other two groups were immunized with 10 mg of peptide or variant peptide combined with the adjuvants. The mice were immunized twice with a 2-wk interval. Nine days after the last immunization, all of the mice were lightly euthanized with isoflurane and intranasally transduced with 2.5 3 10 8 PFU of Ad5-hDPP4 for the rapid generation of a mouse model of MERS-CoV infection (24) . Five days later, the transduced mice were intranasally infected with MERS-CoV (1 3 10 5 PFU) in a total volume of 50 ml of DMEM medium. Three days after infection by MERS-CoV, the mice were euthanatized. Lung and trachea were harvested for pathological examination and virus isolation detection. The immunization and detection schedule is shown in Fig. 6A .
Peptide pool design and synthesis
Peptide pools spanning the entire S protein consisted of 161 short peptides that were coded from 1 to 161. They were synthesized by Beijing SciLight Biotechnology. Each peptide was an18-mer and overlapped by 10 aa with its adjacent peptides. Three matrix peptide pools spanning the entire MERS-CoV S protein were designed for the detection of immunodominant T cell regions (Supplemental Table I ). The subsequently defined short immunogenic CD8 + T cell epitopes were also synthesized as listed in Table I .
ELISPOT assays
To detect MERS-CoV-specific T cell responses, an IFN-g ELISPOT assay was performed as described previously (20) . Briefly, 96-well plates were coated with 100 ml/well of 5 mg/ml anti-mouse IFN-g Ab (BD Pharmingen, San Diego, CA) overnight at 4˚C and then blocked for 2 h at room temperature. Mouse splenocytes, freshly isolated as described previously (25) , were added to the plate (5 3 10 5 /well). Then, the matrix peptide pools (2 mg/ml individual peptide) were added to the wells in duplicate. PMA and ionomycin were added to the positive control group, whereas the negative control group received no stimuli. After an 18-h incubation, a biotinylated detection Ab (BD Pharmingen) and streptavidin-HRP were added. Spots were developed by the addition of a 3-amino-9-ethylcarbazole substrate solution, which produced a colored spot after a 5-to 30-min incubation in the dark at room temperature. Finally, IFN-g spot-forming cells (SFCs) were counted through an ELISPOT reader.
Intracellular cytokine staining
The intracellular cytokine staining assays were conducted as previously described (26) . Briefly, splenocytes (2.5 3 10 6 per sample) were cultured for 4 h at 37˚C in 96-well round-bottom microtiter plates with complete RPMI 1640 culture supplemented with peptide at a concentration of 4 mg/ml. Control cells were incubated with an unrelated peptide or without peptide. Brefeldin A was then added and incubated with the cells for 2 h before staining. The cells were next incubated for 30 min at 4˚C with 50 ml of a 1:100 dilution of an FITC-labeled Ab targeting mouse CD8 and PerCPlabeled anti-CD4. Subsequently, the cells were permeabilized in Cytofix/ Cytoperm for 20 min at 4˚C, washed three times with Perm/Wash buffer, and incubated in the same buffer for 30 min at 4˚C with 50 ml of a 1:100 dilution of allophycocyanin-labeled Ab targeting mouse IFN-g. The results were then detected using a FACSCalibur flow cytometer (BD Biosciences). The above reagents and Abs were purchased from BD Pharmingen.
H&E staining
Histopathological examinations were conducted as previously described (19) . Briefly, lungs and trachea were collected after the mice were euthanatized. Procedures were performed using samples fixed in 10% neutral buffered formalin, embedded in paraffin, sequentially sectioned to 4 mm thickness, and stained with H&E prior to examination by light microscopy.
Virus isolation
The MERS-CoV isolation was conducted on Vero cells. Briefly, the lungs were homogenized to a final 10% suspension in DMEM and clarified by lowspeed centrifugation at 4500 3 g for 30 min at 4˚C. Vero cells (1.5 3 10 4 / well) were seeded in 96-well plates and incubated overnight at 37˚C in a CO 2 incubator. One hundred microliters of 10-fold serially diluted suspension was then added to each well in quadruplicate. The virus was allowed to adsorb onto the cells at 37˚C for 1 h. After adsorption, viral inoculates were removed, and 100 ml of DMEM (2% FBS) was added to each well. Plates were incubated in a CO 2 incubator at 37˚C for 3 d, following which cytopathic effects were microscopically observed at 340 magnification.
Refolding and purification of H-2K d
Murine MHC I H-2K d H chain and human b 2 -microglobulin (b 2 m) were overexpressed as inclusion bodies in the BL21(DE3) strain of Escherichia coli. Renaturation and purification of H-2K d assembled with immunodominant peptides were performed as described previously (27) . Generally, injection and dilution of MHC H chain, b 2 m, and peptide occurred at a molar ratio of 1:1:3 in an L-arginine refolding buffer. After 24 h for protein refolding, the H-2K d complexes were concentrated and exchanged into a buffer of 20 mM Tris-HCl (pH 8) and 50 mM NaCl and then purified using Superdex 200 10/300 GL gel filtration chromatography (GE Healthcare, Beijing, China).
Tetramer preparation and cell staining
H-2K d -restricted tetramers of peptides 37-1, I5A (37-1 variant), and mutant H-2K d (named W73A-restricted tetramers of peptide 37-1) were prepared as previously described (28) . Briefly, to produce biotinylated peptide/MHC protein, H-2K d was modified by the addition of a substrate sequence for the biotinylating enzyme BirA at the C terminus of the a3 domain. In vitro-renatured H-2K d -peptide complexes were then purified and biotinylated by incubation with D-biotin, ATP, and the biotin protein ligase BirA (Avidity) at 4˚C for 12 h. The biotinylated H-2K d was further purified over a Superdex 200 10/300 GL gel filtration column (GE Healthcare) to remove excess biotin and then mixed with PE-streptavidin (Sigma-Aldrich). Cells from the subjects were stained with PE-tetramer and FITC-conjugated anti-CD8 Ab. All samples were analyzed with a FACSCalibur flow cytometer (BD Biosciences) after staining.
Generation of specific T cell lines in vitro
Splenocytes from immunized mice were incubated with peptides in RPMI 1640 containing 10% FBS (HyClone Laboratories) at 37˚C with 5% CO 2 at a density of 2.5 3 10 6 cells/ml in 24-well plates. On day 2, 50 U/ml recombinant mouse IL-2 was added to the medium. Half of the medium was exchanged with supplementation by recombinant mouse IL-2 on days 4 and 7. On day 9, cells were harvested and tested for the presence of MERS-CoV-specific CD8 + T cells by tetramer staining.
Thermostability measurements using circular dichroism
To evaluate the thermostability of H-2K d complexes formed with different peptides, we used the circular dichroism (CD) spectroscopy method as previously described (29) . All complexes were prepared as described above and diluted to 200 mg/ml in 20 mM Tris-HCl (pH 8) and 50 mM NaCl. CD spectra at 218 nm were measured on a Chirascan spectrometer (Applied Photophysics) using a thermostatically controlled cuvette at temperature intervals of 0.1˚C and a rate of 1˚C/min between 20 and 100˚C. The proportion of denatured protein was calculated from the mean residue ellipticity (u) using the standard method: fraction unfolded (%) = (u 2 u N )/(u U 2 u N ), where u N and u U are the mean residue ellipticity values in the fully folded and fully unfolded states, respectively. The midpoint transition temperature (T m ) was calculated using the data from the denaturation curves in the program Origin 8.0 (OriginLab).
X-ray crystallography, structure determination, and refinement
The refolded H2-K d /peptide complexes were further purified through a Resource Q ion exchange column (GE Healthcare), and the concentration of the complexes was adjusted to 5-15 mg/ml. As described previously (30) , crystals were grown by the hanging drop vapor diffusion method at 18˚C. The H2-K d /peptide complex was screened through Crystal Screen kit I/II, the Index Screen kit, and the PEGRx kit (Hampton Research). For cryoprotection, crystals were transferred to reservoir solutions containing 20% glycerol and then flash cooled and maintained at 100 K in a cryostream. X-ray diffraction data were collected at beamline BL17U of the Shanghai Synchrotron Radiation Facility. The structures were determined using molecular replacement with the program CNS (31) . The model used was the structure coordinates with Protein Data Bank (PDB) code 1VGK. Extensive model building was performed by hand using COOT (32) , and restrained refinement was performed using REFMAC5 (33) . The stereochemical quality of the final model was assessed with the program PROCHECK (34) . Structure-related figures were generated using PyMOL (http://www.pymol.org/).
Statistical analysis
The null hypothesis proposed that tested parameters in different immunized mouse groups would not differ significantly from each other. Differences in mean values were evaluated for statistical significance (p , 0.05 or , 0.01) by a Student two-tailed t test. Data were assembled and statistically calculated on computerized spreadsheet programs (Excel [Microsoft] and Prism 5 [GraphPad Software]).
Protein structure accession numbers
The coordinates and structure factors of complexes H-2K d /37-1, H-2K d / 37-3, H-2K d /142-2, H-2K d /142-5, and H-2K d /I5A were deposited in the PDB under accession numbers 5GR7, 5GSB, 5GSX, 5GSV, and 5GSR, respectively.
Results
Immunodominant regions in the MERS-CoV S protein
A detailed immunogenic mapping analysis of the peptides spanning the entire S protein was conducted in mice immunized with the adenoviral-based S protein-encoding vaccine rAd5-S. By crossing the 12 immunogenic matrix peptide pools (Fig. 1A, 1B) inducing high levels of IFN-g secretion ($200 SFCs/10 6 splenocytes), eight different immunodominant peptide regions covering 18 aa were identified in S protein, including five regions in the N-terminal domain, one in the receptor-binding domain, and two in the S2 domain of S protein (Fig. 1D) .
To acquire the shortest immunogenic H2-K d -restricted CD8 + T cell epitopes of the three immunodominant peptides 37, 122, and 142 ($600 SFCs/10 6 splenocytes), the peptides were truncated into short fragments (Table I) . ELISPOT assays were performed to evaluate the T cell responses to these shortened peptides with typical H-2K d -binding peptide motifs (Y/F at P2 position and L/I/V at Pc position). Within all the truncated smaller fragments, the peptides 37-1, 37-3, 122-1, 122-3, 142-2, and 142-5 resulted in almost as high a level of T cell responses as for the original peptides (Fig. 1C, 1D ).
Structure-based determination of epitope clusters in S protein
The 9-mer peptide 37-1 and 10-mer peptide 142-2 are the C-terminal truncations of the longer peptides 37-3 and 142-5, respectively. To determine whether 37-3 and 142-5 were independent epitopes or whether their immunogenicities depended on the shorter peptides 37-1 and 142-2, we determined the molecular structures of all four peptides complexed with H2-K d (Table II) . The overall complex structures of H2-K d with peptides 37-1 ( Fig. 2A ), 37-3 ( Fig. 2B ), 142-2 (Fig. 2C ), and 142-5 ( Fig. 2D ) are similar to other MHC I molecules, with the peptides lying on the bed formed by two a helices and b-sheets in the a1a2 domain of H-2K d . Peptide 37-1 is presented in the groove of H-2K d , with the P2-Tyr and P9-Ile as the primary anchoring residues in pockets B and F, respectively ( Fig. 2A) . Similarly, peptide 142-2 has Tyr 2 and Leu 10 as its primary anchors (Fig. 2C ). Interestingly, peptides 37-3 and 142-5 assume similar conformations as the truncated 37-1 and 142-2 peptides, respectively. No electron densities were observed for the N-terminal residue P1-Lys for 37-3 or N-terminal residue P1-Ser for 142-5. This may indicate that the immunogenicities of peptides 37-3 and 142-5 depend on the shorter peptides 37-1 and 142-2.
Structural shift of H-2K d impelled by MERS-CoV peptide
When comparing the two structures of H-2K d complexed with peptides 37-1 and 142-2, we found that Trp 73 in the a helix of H-2K d had different conformations. In the structure of H-2K d /142-2 (Fig. 3A) , Trp 73 is located under the C-terminal portion of the peptide, which leads to a C-terminal bulged conformation for 142-2 as common H-2K d -presented peptides. In the H-2K d /37-1 complex (Fig. 3B) , however, Trp 73 protrudes out of the H-2K d peptidebinding groove, being solvent exposed and ready for TCR recognition. We compared the Trp 73 of H-2K d /37-1 with the corresponding residue in all previously determined complexes of H-2K d with T cell epitopes derived from HBV (PDB code 1VGK), influenza virus (2FWO), insulin (4WDI), and glucose-6-phosphatase catalytic subunit-related protein (3NWM) (35) (36) (37) . We found that Trp 73 from all of the previously determined structures of H-2K d is pointing
The Journal of Immunology into the groove under the peptides (Fig. 3E ), similar to Trp 73 in the H-2K d /142-2 structure. Only the Trp 73 of H-2K d /37-1 protrudes out of the groove. Further analysis of the structures indicated that the secondary anchor P5-Ile in the middle of peptide 37-1 contributes to the conformational shift of H-2K d Trp 73 . P5-Ile in peptide 37-1 is larger than the corresponding secondary anchors of other peptides in H-2K d complexes. The steric hindrance of peptide 37-1 P5-Ile with the Trp 73 of H-2K d pushes Trp 73 out of the peptide-binding groove. Furthermore, the main chain position of peptide 37-1 is lower in the groove and closer to a1 helix when compared with all other peptides presented by H-2K d (Fig. 3C, 3D ).
Immunogenicity of MERS-CoV peptide affected by peptide/ MHC I inteaction
The uncommon upward protrusion of Trp 73 in the H-2K d structure with peptide 37-1 implies that the T cell recognition of 37-1 may depend on both the unique conformation of the peptide and H-2K d itself. To verify this hypothesis, we immunized BALB/c mice with the cDNA pCAGGS-S vaccine expressing the S protein of MERS-CoV and boosted immunization through the vaccinia vector-based vaccine rVV-Sq. A robust T cell response against peptides 37 (1316 6 31 SFCs/10 5 splenocytes) and 37-1 (1181 6 102 SFCs/10 5 splenocytes) was detected (Fig. 4A ). However, we detected a much lower T cell response (761 6 105 SFCs/10 5 splenocytes) to the mutant peptide I5A containing a substitution at position 5 of 37-1 from Ile to Ala. The decreased antigenicity of I5A compared with 37-1 was also confirmed through intracellular cytokine staining assays ( Fig. 4B ) (1.19% IFN + CD8 + T cells for I5A versus 2.91% IFN + CD8 + T cells for 37-1). Meanwhile, we also detected MERS-CoVspecific T cell responses in the mouse group that was not booster immunized with rVV-Sq. An antigenic decrease of peptide I5A was still observed despite the low T cell responses in these mice (Fig. 4) .
To clarify the mechanistic details of the impact of the peptide/ H-2K d interaction on T cell recognition, we prepared three different MHC tetramers for MERS-CoV-specific T cell detection: 1) H-2K d with peptide 37-1, 2) H-2K d with peptide I5A, and 3) an MHC tetramer W73A comprised of peptide 37-1 and mutant H-2K d with a Trp 73 Ala substitution. For the freshly isolated splenocytes from MERS-CoV vaccine-immunized mice (Fig. 4C, 4D ), 3.56% 37-1-specific CD8 + T cells were detected, much higher than the 0.102% from tetramer prepared with wild-type H-2K d and peptide I5A. The ratio of tetramer W73A-specific T cells was higher than that of I5A but still lower than the wild-type tetramer of the H-2K d / 37-1 complex.
We also established peptide-specific T cell lines by culturing the splenocytes from vaccinated mice under the stimulation of peptides 37-1 and I5A, respectively, to investigate the different immunogenicities of these two peptides. After in vitro stimulation by peptide 37-1 or I5A for 9 d, the 37-1 tetramer-specific CD8 + T cells accounted for 57.6 6 10.3% among the 37-1-cultured cells, higher than the 36.4 6 8.0% among the I5A-cultured splenocytes.
Thus, I5A had a lower ability to stimulate 37-1-specific T cells in vitro compared with wild-type peptide 37-1 ( Fig. 4E, 4F ).
To further demonstrate the molecular basis for the concordant T cell recognition of MERS-CoV-derived CD8 + T cell epitopes and host MHC I, we determined the binding affinity of mutant I5A to H-2K d through in vitro refolding (Fig. 5A) and CD (Fig. 5B ). We found that mutant I5 (46˚C) has a similar binding affinity for H2-K d as does peptide 37-1 (45˚C), with comparable T m s. This indicated that substitution from Ile 5 to Ala 5 in peptide 37-1 does not influence the peptide-binding affinity to H-2K d . Instead, the major antigenic variance of I5A compared with 37-1 may be contributed by conformational shifts in both the peptide and H-2K d itself. To verify this hypothesis, we determined the x-ray crystal structure of H-2K d complexed to the 37-1 mutant I5A. As expected based on our hypothesis, the Trp 73 in H-2K d /I5A was lower into the groove due to sufficient space left by the P5-Ala of peptide I5A (Fig. 5C ). The main chain conformation of peptide I5A also shifts back to the traditional C-terminal bulged position (Fig. 5D ). The position of I5A is higher than 37-1, especially the His 7 of I5A, which is boosted by Trp 73 from beneath.
Based on the structures of H-2K d complexed with 37-1 and I5A, we deduced that our W73A tetramer (with wild-type peptide 37-1 and the H-2K d Trp 73 Ala mutant) had an intermediate structure between H-2K d /37-1 and H-2K d /I5A. In the W73A tetramer, the conformation of peptide 37-1 would remain the same as in the structure of H-2K d / 37-1, and the mutation of Trp to Ala at position 73 of H-2K d would be the only difference from the wild type. Thus, the tetramer W73Aspecific T cells had an intermediate ratio, higher than that of H-2K d / I5A and lower than the wild-type tetramer of H-2K d /37-1.
The MHC conformation-concordant protective effect of peptide 37-1
To investigate the protective effect of peptide 37-1 against MERS-CoV infection and its molecular basis, we used our previously established mouse model of MERS-CoV infection (Fig. 6A) (24) . The mice immunized with peptide 37-1 had a quicker body weight recovery after MERS-CoV challenge compared with the adjuvant IFA/Gp97-immunized mouse group, although without a significant difference (Fig. 6B) . The virus titers of the 37-1 group were much lower than those of the adjuvant group on day 3 after virus challenge, indicating quick virus clearance by 37-1-specific T cells (Fig. 6C) . The histopathological examinations of lungs and trachea in the MERS-CoV-infected mice revealed that the inflammatory responses in both the bronchiole and alveolus were milder in 37-1-immunized mice than the adjuvant IFA/Gp97-immunized group (Fig. 6D) .
No protective effect of the peptide I5A-specific T cell response against MERS-CoV was observed, as revealed by similar virus titers of the mice immunized with I5A and the adjuvant IFA/Gp97 (Fig. 6C ). This indicates that the protective effect of peptide 37-1 depends on the unique structural orchestration of this MERS-CoV-derived peptide and the host MHC I itself.
Discussion
Four years have elapsed since the first MERS-CoV case was reported in the Middle East. However, studies on MERS-CoV-specific T cell immunity and its protective effect are still ongoing. In this study, we evaluated the T cell immunodominance of the MERS-CoV S protein by using the overlapping peptides spanning the whole protein. A concordant recognition of MERS-CoV-derived novel CD8 + T cell epitopes and host MHC I by specific T cells was shown. Furthermore, the protective effect provided by the coordinated T cell responses and the molecular basis of this phenomenon were demonstrated. Our study sheds light on a new mechanism of virus-specific T cell recognition and may impact vaccine development for MERS-CoV.
Natural infection with severe acute respiratory syndrome coronavirus (SARS-CoV) and inoculation with related vaccines give rise to dominant responses against the structural Ags of SARS-CoV in FIGURE 4 . Conformation-dependent antigenicity of peptide 37-1. (A) The peptide 37-, 37-1-, and I5A (the mutant of 37-1 at position 5 from Ile to Ala)specific T cell responses were detected through IFN-g by using freshly isolated splenocytes from MERS-CoV vaccine-immunized mice. pCAGGS-S, BALB/c mice were immunized with cDNA pCAGGS-S vaccine expressing S protein only; pCAGGS-S+rVV-Sq, BALB/c mice were immunized through a prime of cDNA pCAGGS-S vaccine expressing S protein, followed by a boost through a vaccinia vector vaccine rVV-Sq carrying the ectodomain of S protein. (B) Intracellular cytokine staining was manipulated to detect the peptide-specific CD8 + T cells. Different peptides were used as stimulators to induce the secretion of IFN-g before the test. The samples without peptide stimulation (No Pep) were used as negative controls. Lymphocytes were gated through the side light scatter/ forward light scatter parameters. CD8 + T cells were subsequently selected for the secretion of IFN-g. (C) The MERS-CoV-specific CD8 + T cells in the freshly isolated splenocytes from vaccinated mice were stained with tetramers 37-1 (complexes between H-2K d and wild-type peptide 37-1), I5A (complexes between H-K d and mutated peptide I5A), and W73A (complexes between the H-2K d Trp 73 Ala mutant and wild-type peptide 37-1). Lymphocytes were gated through the side light scatter/forward light scatter parameters. CD8 + T cells were subsequently selected for the analysis of tetramers. (D) Statistical analysis of the tetramer + CD8 + T cells among total CD8 + T cells in (C). (E) The splenocytes from vaccinated mice were cultured in vitro for 9 d under the stimulation of peptide 37-1 and I5A, respectively. On day 9, the MERS-CoV-specific CD8 + T cell lines were analyzed by the staining of tetramers 37-1 and I5A. (F) Statistical analysis of the tetramer 37-1 staining of the T cell lines established by in vitro culturing using peptides 37-1 and I5A, respectively. *p , 0.05, **p , 0.01, ***p , 0.001. humans and animals (38, 39) . Xu and coworkers (40) detected SARS-CoV-specific T cell responses among PBMCs from donors who recovered from SARS using overlapping peptides covering the entire SARS-CoV proteome. They found that most of the antigenic peptides are located in the structural proteins (especially S protein) rather than in nonstructural proteins. Meanwhile, several HLA-A2-restricted CD8 + T cell-specific epitopes derived from the SARS-CoV S proteins have been identified (41) (42) (43) . All of these data from SARS-CoV imply a crucial role of S protein as a T cell immunodominant Ag for coronaviruses. For MERS-CoV, several H-2 d -and H-2 b -restricted CD8 + T cell epitopes have recently been identified through an in vitro T cell epitope prediction strategy using the mouse model sensitized to MERS-CoV infection (24) . In the present study, we evaluated the cellular immunodominant regions of the entire MERS-CoV S protein. Several previously identified CD8 + T cell epitopes (24) were included in the immunodominant regions we defined, which corroborates our studies. The identified cellular immunodominant regions of the S protein will be helpful for MERS-CoV-specific T cell studies using animal models and for the development of vaccines (44) (45) (46) .
Previously, we defined a clustering region of CTL epitopes within the transmembrane region of the M protein (25, 47) . The antigenic 9-mer peptide Md3-C9 (LACFVLAAV) is the C-terminal truncation of the 10-mer T cell epitope Md3 (TLACFVLAAV). The crystal structure of HLA-A*0201 complexed with peptide Md3
(PDB code 3I6K) shows that the peptide conformation is different from the structure of Md3-C9 (PDB code 3TO2) via the use of a distinct P2 anchor residue. This indicates that the antigenicity of Md3 is independent of its C-terminal truncation Md3-C9. In our current crystal structures of H-2K d , the peptide conformation and the anchoring residues of the 10-mer peptide 37-3 and 11-mer peptide 142-5 are similar to their C terminal truncations, that is, the 9-mer peptide 37-1 and the 10-mer peptide 142-2, respectively. This indicates that the antigenicities of peptide 37-3 and 142-5 are dependent on the shorter peptides 37-1 and 142-2. The T cell repertoires of the peptides 37-3 and 142-5 may also largely overlap with peptides 37-1 and 142-2, with an eye to the commonly shared TCR repertoire by different but mimic peptides (48) . In the structures, no electron densities for the P1-Lys of 37-3 or P1-Ser of 142-5 can be observed, perhaps due to the flexibility of these residues. Another possibility is that these residues may have been degraded during crystal growth. However, during the T cell responses in mice infected with MERS-CoV, 37-3 and 142-5 may still be naturally processed and presented by H-2K d . Additionally, these peptides with residues protruding out of the N terminus of the peptide-binding groove may be recognized by specific TCRs and induce unique T cell repertoires that are different from the one of 37-1 and 142-2.
In the present study, the mice immunized with peptide 37-1 together with murine Gp96 protein had a lower virus titer and quicker body weight recovery after MERS-CoV infection. This indicates the important role of T cells for anti-MERS-CoV vaccine development, comparable to the previous discovery on SARS-CoV peptide vaccines (44) . However, no protective effect against MERS-CoV infection can be observed after the preemptive immunization of the mutated peptide I5A. This can be partially explained by the altered exposed surface of the peptide and the induced fit of Trp 73 of host MHC I. In previous studies on influenza virus-derived peptides and T cell immunity-escaping mutants, the engineered viruses with the mutated sites within T cell epitopes induced diminished CD8 + T cell responses and selected narrowed TCR repertoires (49, 50) . This can be partially explained by the MHC/ peptide structures that showed a loss of contacts between the peptides and His 155 of H-2D b (50) , or the altered topography of His 155 (49) , a position known to play an important role in mediating TCR/ MHC interactions. In our study, minimal MERS-CoV-specific T cells can be stained by the mutant I5A tetramer compared with the wild-type peptide 37-1 tetramer, which may also reflect a narrowed TCR repertoire corresponding to I5A.
It has been indicated that peptides impose subtle structural transitions on MHC molecules that affect T cell recognition and may thus be critical for virus clearance by T cell responses (49, 50) .
Previously, we determined the structure of bovine MHC I N*01801 complexed with a rinderpest virus epitope, which shows two distinct conformations (51) . A detailed analysis of the structure revealed that the polymorphic amino acid Ile 73 within the MHC groove has a propensity to adopt different conformations to accommodate the rinderpest virus peptide. Interestingly, in our present structure of H-2K d /37-1, the Trp that displays an induced conformation is also at position 73. Thus, the polymorphic amino acid in position 73 of MHC I from different mammals may act as a key residue for the peptide/MHC I interaction, impacting the T cell recognition.
Our data provide a novel MHC I and peptide resonant interaction for subsequent protective T cell immunity and may aid in vaccine development for emerging infectious viruses such as MERS-CoV. 
